Skip navigation
Agenda

Strategies to Effectively Scale the Business and Best Practices for Accounting and Reporting

September 25-26, 2018
  • Boston, MA

Agenda

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, SEPTEMBER 25, 2018

7:30

Registration and Continental Breakfast

8:30

Conference Co-Chairs’ Welcome and Opening Remarks

Nancy Aubrey
Risk Advisory Services, Life Sciences Industry
RSM US LLP

John Lanza
National Life Sciences Industry Leader
RSM US LLP

Strategies to Drive Growth and Commercial Success in an Innovative Life Sciences Company

8:45

OPENING KEYNOTE PANELLeading in Finance and Creating Value —
The Art and Science of the CFO in Today’s Cutting-Edge Biopharma Company

MODERATOR:

William T. Roberts
Partner, Americas Financial Accounting Advisory Services
Ernst & Young LLP

PANELISTS:

Chris Lindblom
Vice President, Finance and Operations
Warp Drive Bio

Ted Myles
Executive Vice President and Chief Financial Officer
AMAG Pharmaceuticals

Kory Wentworth
Vice President, Finance and Principal Accounting Officer
bluebird bio

9:30

Trademarks of High-Performing Finance/Accounting Teams and Talent Sourcing Strategies

Speaker TBA

10:15

Networking and Refreshment Break

10:45

FINANCING UPDATECapital Markets Update and Overview —
Deal-Making and Exit Strategies Prevailing in the Life Sciences Sector

Ryan Udell
Partner and Co-Chair, Corporate and Securities Group
White and Williams LLP

11:30

IPO PANELIPO Watch-Outs and Insights for Transitioning, Commercializing and
Scaling the Business

PANELISTS:

Marc Belsky
Chief Financial Officer
Kezar Life Sciences

Dominic Piscitelli
Chief Financial Officer
AnaptysBio

12:15

Networking Luncheon

Market Trends, Regulations and Healthcare Sector Forces of Change

1:30

Product Pricing Pressures and Trends within the Payer Marketplaces

Speaker TBA

2:15

Corporate Tax Reform and Key Implications to Life Sciences Companies

Speaker TBA

3:00

Prevailing Issues in Risk Management and Strategies for Third-Party
Contract Compliance

Nancy Aubrey
Risk Advisory Services, Life Sciences Industry
RSM US LLP

3:45

Networking and Refreshment Break

4:15

CHOOSE BETWEEN TWO IN-CONFERENCE SUMMITS (I-II)

I. Women’s Leadership Summit

Spotlights power players in the Finance function and shares stories on career paths, mentorship and leadership.

FACILITATOR:

Nancy Aubrey
Risk Advisory Services,
Life Sciences Industry
RSM US LLP

PANELISTS:

Gisele Dion
Group Vice President,
Corporate Controller
Shire

Nancy Dong
Vice President, Finance & Administration
ContraFect Corp.

Daphne Quimi
Senior Vice President – Finance and Administration, Corporate Controller
Amicus Therapeutics Inc.

Amy Diebler
Vice President, Finance and
Chief Financial Officer
Chiesi USA Inc.

 

II. Financial Transformation and Enterprise Systems Excellence Summit

Shares strategies for small-midsize companies to leverage enterprise systems to advance the business with transparency and enhanced decision-making.

Bill Kracunas
Principal and National Management Consulting Leader
RSM US LLP

5:30

Close of Day One

Networking, Wine and
Cheese Reception
immediately following the final session
Hosted by:

DAY TWO WEDNESDAY, SEPTEMBER 26, 2018

7:15

Continental Breakfast

8:15

Conference Co-Chairs’ Review of Day One

Nancy Aubrey
Risk Advisory Services, Life Sciences Industry
RSM US LLP

John Lanza
National Life Sciences Industry Leader
RSM US LLP

Hot Topics in Accounting and SEC Reporting

8:30

SEC Hot Topics, Regulatory Issues and Comment Letter Review

Ryan Dolan
Partner, Co-Leader of Life Sciences Practice
CFGI

9:15

PANEL DISCUSSIONLease Accounting and Effective Implementation of ASC 842

MODERATOR:

Mike Gregorski
Partner, National Director of Risk - Technical Accounting Consulting
RSM US LLP

PANELISTS:

Sima Basher
Associate Director, Corporate Consolidation & Financial Reporting
Bristol-Myers Squibb

Dan Carlson
Consultant, Accounting and Financial Reporting
Eli Lilly & Co

Robert Auslander
Vice President Technical Accounting and Policy
Valeant Pharmaceuticals

10:00

Networking and Refreshment Break

10:30

Implications of the New Revenue Recognition Standard

Speaker TBA

11:15

Deals, Licensing and R&D Collaborations —
Best Practices for Accounting and Reporting

Kelly MacDonald
Senior Director, Financial Planning & Analysis
Ironwood Pharmaceuticals

Sabrina Basu
Director, External Reporting, Technical Accounting and Internal Controls
Ironwood Pharmaceuticals

12:00

Networking Luncheon

Commercialization Strategies and Business Models for New Product Success

1:00

Product Commercialization Strategies for New Launch Success

Richard Capasso
Executive Director
Ernst & Young LLP

1:45

Financial Considerations and Best Practices for Contracting in
Commercial Channels

Michelle Ross
North America Head of Finance
Guerbet LLC

2:30

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, SEPTEMBER 25, 2018

7:30

Registration and Continental Breakfast

8:30

Conference Co-Chairs’ Welcome and Opening Remarks

Nancy Aubrey
Risk Advisory Services, Life Sciences Industry
RSM US LLP

John Lanza
National Life Sciences Industry Leader
RSM US LLP

Strategies to Drive Growth and Commercial Success in an Innovative Life Sciences Company

8:45

OPENING KEYNOTE PANELLeading in Finance and Creating Value —
The Art and Science of the CFO in Today’s Cutting-Edge Biopharma Company

MODERATOR:

William T. Roberts
Partner, Americas Financial Accounting Advisory Services
Ernst & Young LLP

PANELISTS:

Chris Lindblom
Vice President, Finance and Operations
Warp Drive Bio

Ted Myles
Executive Vice President and Chief Financial Officer
AMAG Pharmaceuticals

Kory Wentworth
Vice President, Finance and Principal Accounting Officer
bluebird bio

9:30

Trademarks of High-Performing Finance/Accounting Teams and Talent Sourcing Strategies

Speaker TBA

10:15

Networking and Refreshment Break

10:45

FINANCING UPDATECapital Markets Update and Overview —
Deal-Making and Exit Strategies Prevailing in the Life Sciences Sector

Ryan Udell
Partner and Co-Chair, Corporate and Securities Group
White and Williams LLP

11:30

IPO PANELIPO Watch-Outs and Insights for Transitioning, Commercializing and
Scaling the Business

PANELISTS:

Marc Belsky
Chief Financial Officer
Kezar Life Sciences

Dominic Piscitelli
Chief Financial Officer
AnaptysBio

12:15

Networking Luncheon

Market Trends, Regulations and Healthcare Sector Forces of Change

1:30

Product Pricing Pressures and Trends within the Payer Marketplaces

Speaker TBA

2:15

Corporate Tax Reform and Key Implications to Life Sciences Companies

Speaker TBA

3:00

Prevailing Issues in Risk Management and Strategies for Third-Party
Contract Compliance

Nancy Aubrey
Risk Advisory Services, Life Sciences Industry
RSM US LLP

3:45

Networking and Refreshment Break

4:15

CHOOSE BETWEEN TWO IN-CONFERENCE SUMMITS (I-II)

I. Women’s Leadership Summit

Spotlights power players in the Finance function and shares stories on career paths, mentorship and leadership.

FACILITATOR:

Nancy Aubrey
Risk Advisory Services,
Life Sciences Industry
RSM US LLP

PANELISTS:

Gisele Dion
Group Vice President,
Corporate Controller
Shire

Nancy Dong
Vice President, Finance & Administration
ContraFect Corp.

Daphne Quimi
Senior Vice President – Finance and Administration, Corporate Controller
Amicus Therapeutics Inc.

Amy Diebler
Vice President, Finance and
Chief Financial Officer
Chiesi USA Inc.

 

II. Financial Transformation and Enterprise Systems Excellence Summit

Shares strategies for small-midsize companies to leverage enterprise systems to advance the business with transparency and enhanced decision-making.

Bill Kracunas
Principal and National Management Consulting Leader
RSM US LLP

5:30

Close of Day One

Networking, Wine and
Cheese Reception
immediately following the final session
Hosted by:

DAY TWO WEDNESDAY, SEPTEMBER 26, 2018

7:15

Continental Breakfast

8:15

Conference Co-Chairs’ Review of Day One

Nancy Aubrey
Risk Advisory Services, Life Sciences Industry
RSM US LLP

John Lanza
National Life Sciences Industry Leader
RSM US LLP

Hot Topics in Accounting and SEC Reporting

8:30

SEC Hot Topics, Regulatory Issues and Comment Letter Review

Ryan Dolan
Partner, Co-Leader of Life Sciences Practice
CFGI

9:15

PANEL DISCUSSIONLease Accounting and Effective Implementation of ASC 842

MODERATOR:

Mike Gregorski
Partner, National Director of Risk - Technical Accounting Consulting
RSM US LLP

PANELISTS:

Sima Basher
Associate Director, Corporate Consolidation & Financial Reporting
Bristol-Myers Squibb

Dan Carlson
Consultant, Accounting and Financial Reporting
Eli Lilly & Co

Robert Auslander
Vice President Technical Accounting and Policy
Valeant Pharmaceuticals

10:00

Networking and Refreshment Break

10:30

Implications of the New Revenue Recognition Standard

Speaker TBA

11:15

Deals, Licensing and R&D Collaborations —
Best Practices for Accounting and Reporting

Kelly MacDonald
Senior Director, Financial Planning & Analysis
Ironwood Pharmaceuticals

Sabrina Basu
Director, External Reporting, Technical Accounting and Internal Controls
Ironwood Pharmaceuticals

12:00

Networking Luncheon

Commercialization Strategies and Business Models for New Product Success

1:00

Product Commercialization Strategies for New Launch Success

Richard Capasso
Executive Director
Ernst & Young LLP

1:45

Financial Considerations and Best Practices for Contracting in
Commercial Channels

Michelle Ross
North America Head of Finance
Guerbet LLC

2:30

Close of Conference